With over 25 years of experience in the pharmaceutical industry, I am Senior Director of Medical Affairs and Value Statistics at Jazz Pharmaceuticals. I lead an experienced team of highly talented statisticians exploring questions of efficacy, safety and value of Jazz medications via post hoc analysis of clinical trial data, post-launch prospective clinical trials and real world evidence. I am passionate about applying advanced analytics and innovative methods to generate evidence that supports the development and commercialization of life-changing therapies. I have a Ph.D. in mathematical statistics and probability with a strong background in both randomized clinical trials and observational research. I shine at the intersection of study concepts and implementation, refining protocol designs and analysis plans to decisively answer research objectives. I strive to right size mathematical complexity to fully probe issues while emphasizing clear, simple explanations and graphics to facilitate interpretation. I have led statistical teams for FDA and EMA drug registrations in pulmonary disease and osteoporosis. I have also led health outcomes research on the acute treatment of migraine including development of budget impact and cost-effectiveness models, dossier creation, and interactions with ICER. I have multiple publications and have collaborated with leading academic and industry partners in oncology and Alzheimer’s disease.
Listed skills include Pharmaceutical Industry, Oncology, Drug Development, Clinical Development, and 1 others.